Qiao Zhou earned his M.D. (1984) and M.A. (1987) degrees in pathology and worked as a Pathologist (1987-1994) in West China Medical School, Chengdu, China. In 1994, he joined Dr. G. Salvesen’s group at the Pathology Department, Duke University, USA, where he earned his Ph.D. degree in pathology (1998) with research on apoptosis. He also worked as a Research Fellow and as a Research Associate in La Jolla Cancer Research Foundation (now Sanford-Burnham Institute) in San Diego, Calif, USA (1996-1998) and Harvard Medical School (1999-2000). Since 2001, he has became a Professor and the Vice Chair of the Pathology Department and the Director of Pathology Research Laboratories of West China Hospital and Medical School. His work covers diagnostic pathology (with particular interests in genitourinary pathology, neuropathology, and dermatopathology), teaching and graduate student training, and research in both diagnostic and molecular pathology. Supported by grants from the National Science Foundation of China (NSFC), the Ministries of Science and Technology and Education, his group’s research has focused on molecular biology of cancer, especially the roles of apoptosis (notably caspases, inhibitor of apoptosis proteins, and Bcl-2 family molecules) and gene expression regulation (transcription, HIF-1a signaling, epigenetics, and microRNAs) in prostate and urinary bladder cancer, brain tumors, and melanoma, and his work has been published in Cancer Research, Journal of Biological Chemistry, American Journal of Pathology, Journal of Neuropathology and Experimental Neurology, Modern Pathology, Human Pathology, Journal of Clinical Pathology, and American Journal of Clinical Pathology. He serves on the editorial boards of several medical textbooks and journals, as a Member in several international and national academic societies, and as a Reviewer for government research funding committees.
Biography Updated on 15 April 2013